Global Registry for Emerging Invasive Fungal Infections to Improve Diagnosis and Treatment

What this Trial Is About

Researchers are gathering detailed information on invasive fungal infections caused by emerging fungi worldwide. This observational registry aims to identify the fungal species responsible in different regions, understand how the disease presents, and document the diagnostic methods used. It also seeks to describe treatment approaches and their effectiveness, as well as promote sharing of clinical fungal samples and develop molecular tools for better strain identification. This registry collects data through a web-based platform where cases of invasive fungal infections confirmed by culture, histopathology, antigen, or DNA evidence are recorded. The focus is on emerging fungal infections, excluding common fungi like Candida, Cryptococcus neoformans, Pneumocystis jiroveci, and endemic fungal infections. Participants are not receiving specific treatments through this study instead, their clinical information and diagnostic results are documented for analysis. Participants provide clinical data that include diagnostic procedures and treatment regimens used. Researchers monitor treatment effectiveness at 90 days from diagnosis as the primary outcome. The study involves no direct intervention and continues to collect data over time to improve understanding of these infections. Participation duration varies as the registry is ongoing, with data collected at diagnosis and follow-up points.

FungiScope - A Global Emerging Fungal Infection Registry